Recent News Releases
Study to evaluate whether drug works better against tumors with specific genetic anomaly.
A new clinical trial is testing whether targeting treatments to a genetic anomaly can lead to better treatments for prostate cancer. The trial, led by investigators at the University of Michigan Comprehensive Cancer Center, is being conducted at 11 sites throughout the country.
U-M study finds peripherally inserted central catheters - an often preferred route for delivery of IV medications - increase risk of blood clots in sickest patients.
Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications.
But compared to other central venous catheters (CVCs), these commonly-used catheters (known as PICCs) more than double the risk of dangerous blood clots - especially among patients who are critically ill or who have cancer.
Cancer cells are wily, well-traveled adversaries, constantly side-stepping treatments to stop their spread.
But for the first time, scientists at the University of Michigan have decoded the molecular chatter that ramps certain cancer cells into overdrive and can cause tumors to metastasize throughout the body.
- 12.11.12 Capturing circulating cancer cells could provide insights into how disease spreads
- 12.11.12 Anti-aging gene identified as tumor suppressor in mice, research finds
- 12.09.12 New drug cuts risk of deadly transplant side effect in half
- 12.07.12 Cognitive problems may be present before chemotherapy in women with breast cancer
- 12.05.12 Ponatinib acts against the most resistant types of chronic myeloid leukemia
- 12.04.12 Drug shows promise in prostate cancer spread to bone
- 12.04.12 U-M study finds overuse of diagnostic imaging prevalent in patients with early stage breast cancer
- 11.27.12 Most women who have double mastectomy don't need it
- 11.12.12 Spread of human melanoma cells in mice correlates with clinical outcomes in patients, study finds
- 10.29.12 U-M Cancer Center gets $28.4 million grant from NCI
- 10.17.12 SARC receives $11.5 million award for collaborative translational sarcoma research
- 10.08.12 U-M startup Compendia Bioscience acquired by Life Technologies
- 10.08.12 The University of Michigan's Breast Oncology Program to Benefit from QVC Presents 'FFANY Shoes on Sale'
- 10.01.12 Smoking, heavy drinking linked to earlier onset of pancreatic cancer